Home
Breast & breast cancer
Breast cancer Benign breast lesions Prophylactic mastectomy
Breast reconstruction
All techniques Implant reconstruction Latissimus dorsi flap DIEP flap (abdomen) Gracilis flap (thigh) Fat grafting (lipofilling) Flat closure Intimate surgery
Benign gynaecological surgery
Uterus Ovaries and tubes Cervix Vulva and vagina
Gynaecological cancers
Cervical cancer Ovarian cancer Uterine cancer Vulvar cancer Borderline tumours Articles About
Request a callback Book on Doctolib →
Dr Zeitoun, smiling, sees a young patient in consultation, on either side of his desk.
Breast cancer

Breast cancer in young women before 40

Your biopsy report mentions breast cancer, and you are under forty. At this age, the diagnosis is unexpected: it remains uncommon, even though it has been rising steadily for thirty years.

Dr Jérémie Zeitoun
In brief

Treatment follows the same principles as at any age, and it does not mean that a mastectomy will necessarily be needed. What changes is what the work-up must also take into account: often dense breasts, a possible genetic predisposition, your fertility, a future pregnancy plan, and your personal and working life.

This article is based in particular on the SENORIF 2025-2026 guidelines.

You have just learned that you have breast cancer, at an age when this diagnosis is uncommon?

Bring the biopsy report and the images. Dr Jérémie Zeitoun, surgical oncologist and breast surgeon, sees you at the practice at 241 rue du Faubourg Saint-Honoré (Paris 8th) and at Clinique Hartmann (Neuilly-sur-Seine). Surgery takes place at Clinique Hartmann.

A video consultation is possible. You can book an appointment on Doctolib or request a callback from the secretariat.

DIAGNOSIS

Diagnosis: lump, imaging, biopsy

Ultrasound-guided breast core biopsy performed by a female radiologist, the patient partly covered by a sheet.

When to see a doctor

In a young woman, a breast lump is most often benign. It can also be a cancer. See a doctor without delay if you have a new lump, skin or nipple retraction, bloody nipple discharge, persistent redness, or a lymph node in the armpit.

Imaging

Before 40, the breasts are frequently dense: the gland can hide an abnormality on a mammogram. Breast ultrasound, performed by the radiologist, is therefore particularly useful.

The work-up includes a mammogram and an ultrasound of both breasts and both armpits, especially in the case of invasive cancer, whose cells have crossed the wall of the ducts, or of extensive ductal carcinoma in situ. A breast MRI, magnetic resonance imaging, is offered before 40 to define the extent of the lesion and look for other foci; contrast-enhanced mammography, a mammogram with injection of a contrast agent, can replace it.

What the examinations look at

The abnormality, both breasts, the lymph nodes

These examinations look at the abnormality — a mass, a distortion or a focus of microcalcifications —, the rest of the breast, the other breast and the lymph nodes. An image classified ACR 4 or ACR 5 indicates that a sample is needed; it is not yet a diagnosis.

Core needle biopsy

Diagnosis under the microscope

The diagnosis relies on a core needle biopsy, performed by the radiologist under local anaesthesia. The surgeon then sees you, with the reports and the images.

The analysis specifies whether the lesion is in situ or invasive, its grade, and the markers studied by immunohistochemistry, a staining of the cells under the microscope: hormone receptors and HER2 protein. The time to get the result depends on the laboratory.

FERTILITY

Preserving fertility before systemic treatment

Oncofertility consultation: a female doctor takes notes facing a young woman, with a model of the uterus and ovaries on the desk.

Chemotherapy can reduce the number of follicles in the ovary. This effect depends on the drugs, the dose and your age; it is more marked after 35. Amenorrhoea, the absence of periods, does not reflect the ovarian reserve.

The oncofertility consultation

The guidelines require that women of childbearing age be systematically informed, whether or not they already have a plan to have children. An oncofertility consultation is offered to those who wish it, as early as possible and before the start of systemic treatment. If preservation is considered, it is planned without delaying cancer care.

The technique most often discussed is cryopreservation, preservation by freezing, of mature eggs or embryos after ovarian stimulation. In the case of hormone-sensitive cancer, stimulation is discussed case by case, often after surgery.

During chemotherapy

An LH-RH agonist

An LH-RH agonist is a drug that puts the ovaries at rest. Prescribed during chemotherapy, it makes the ovaries less active at the time they are exposed to its toxicity.

The aim is to better protect their function: periods are more likely to return after treatment, and the chances of a later pregnancy increase, with reassuring data regarding the cancer. The monthly injections start at least one week before the first chemotherapy and continue until two weeks after the last.

Fertility preservation and the choice between conserving the breast or performing a mastectomy are discussed now, before systemic treatment.

Dr Zeitoun examines the breasts, reviews the imaging and explains the surgical options to you. He makes sure that oncofertility and, if indicated, cancer genetics are organised in time. Appointment on Doctolib, video consultation or request a callback from the secretariat.

CONTRACEPTION

Contraception during and after treatment

During and after

Effective contraception

Pregnancy must be avoided during treatment. Effective contraception is therefore necessary, even when periods have stopped: the absence of periods does not protect against pregnancy. This contraception continues after treatment, until the team following you agrees to a pregnancy plan.

The methods

Without hormones

All hormonal contraception is contraindicated, including a hormonal IUD. A copper intrauterine device, condoms, or sterilisation for contraceptive purposes, after the reflection period required by law, can be offered.

TREATMENTS

Systemic treatments and hormone therapy

Young woman wearing a headscarf, seated in a day-hospital armchair by a window, reading a book during her infusion.

Systemic treatment — chemotherapy, hormone therapy, immunotherapy or targeted therapy — and radiotherapy are discussed at a multidisciplinary team meeting.

Chemotherapy

Chemotherapy is often discussed in young women, especially in the case of a high-grade tumour, lymph node involvement or a triple-negative or HER2-positive form. It can be given after the operation, or before: this is called neoadjuvant chemotherapy. It must not start before fertility has been addressed.

Hormone therapy

If the tumour has hormone receptors, hormone therapy is offered, generally for five years, sometimes longer. In a woman who is not menopausal, two options are discussed: tamoxifen, alone or combined with ovarian suppression by an LH-RH agonist; or an aromatase inhibitor combined with ovarian suppression, recommended when chemotherapy is indicated or in the case of high clinical risk. Ovarian suppression stops periods for the duration of treatment; hot flushes and vulvovaginal dryness are common.

Depending on the tumour type

Genomic test, targeted therapy, immunotherapy

A genomic test can, in some hormone-sensitive cancers, help estimate the benefit of chemotherapy. Targeted therapy or immunotherapy is discussed according to the type of tumour.

FOLLOW-UP

Follow-up after treatment

Follow-up breast ultrasound: a female radiologist moves the probe over the outer edge of the breast; the patient’s face is uncovered, she is calm, lying on the examination table.

Follow-up includes a clinical examination every six months for five years, then once a year, an annual mammogram for life, and an annual ultrasound, particularly useful when the breasts are dense. No whole-body imaging is routine in the absence of symptoms. On tamoxifen, a pelvic ultrasound is not routine, unless there are symptoms.

What to report

When to get in touch without waiting

Report without waiting a new lump, a change in the scar, a lymph node, persistent bone pain or an unusual cough.

Frequently asked questions

Do I necessarily need a mastectomy because I am young?

No. Age alone does not require a mastectomy. When it is feasible, the first-line treatment is a lumpectomy followed by radiotherapy. See lumpectomy or mastectomy.

Is breast cancer more common than before in young women?

Yes. In France, the incidence rate in women aged 30 rose from 16.1 to 26.3 cases per 100,000 women per year between 1990 and 2023, and from 98.7 to 131.2 in women aged 40.

When should fertility preservation be discussed?

Before the start of systemic treatment, and as early as possible after diagnosis, in an oncofertility consultation.

Will I be able to have a child after treatment?

Yes, after localised breast cancer that has been treated and is in complete remission, generally after waiting two to three years and after the opinion of a multidisciplinary team meeting. Pregnancy does not increase the risk of recurrence.

Which contraception during treatment?

All hormonal contraception is contraindicated. A copper intrauterine device or condoms can be offered. The absence of periods is not enough.

Should I have a genetic test?

Breast cancer before 41 is an indication for a cancer genetics consultation. The analysis concerns in particular the BRCA1 and BRCA2 and PALB2 genes.

Can I ask for a second opinion?

Yes. It does not delay treatment when it is organised quickly. See second opinion for breast cancer.

What are Dr Zeitoun’s fees?

Dr Zeitoun practises in Sector 2 (non-OPTAM) and charges fees above the French Social Security rate for all consultations and procedures. Most international patients are not covered by French Social Security. A detailed quote is given during the consultation, before any procedure. If you are covered, the Assurance Maladie reimburses on the basis of the Social Security rate, and your health insurance may cover all or part of the additional fees, depending on your policy.

FREN
ONLINE CONSULTATIONVideo consultation · by appointment